• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效通气囊驱动干粉吸入器的研制。

Development of high efficiency ventilation bag actuated dry powder inhalers.

机构信息

Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, VA, United States; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA, United States.

Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, VA, United States; Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA, United States.

出版信息

Int J Pharm. 2014 Apr 25;465(1-2):52-62. doi: 10.1016/j.ijpharm.2014.01.043. Epub 2014 Feb 7.

DOI:10.1016/j.ijpharm.2014.01.043
PMID:24508552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4051231/
Abstract

New active dry powder inhaler systems were developed and tested to efficiently aerosolize a carrier-free formulation. To assess inhaler performance, a challenging case study of aerosol lung delivery during high-flow nasal cannula (HFNC) therapy was selected. The active delivery system consisted of a ventilation bag for actuating the device, the DPI containing a flow control orifice and 3D rod array, and streamlined nasal cannula with separate inlets for the aerosol and HFNC therapy gas. In vitro experiments were conducted to assess deposition in the device, emitted dose (ED) from the nasal cannula, and powder deaggregation. The best performing systems achieved EDs of 70-80% with fine particle fractions <5 μm of 65-85% and mass median aerodynamic diameters of 1.5 μm, which were target conditions for controlled condensational growth aerosol delivery. Decreasing the size of the flow control orifice from 3.6 to 2.3mm reduced the flow rate through the system with manual bag actuations from an average of 35 to 15LPM, while improving ED and aerosolization performance. The new devices can be applied to improve aerosol delivery during mechanical ventilation, nose-to-lung aerosol administration, and to assist patients that cannot reproducibly use passive DPIs.

摘要

开发并测试了新型主动干粉吸入器系统,以有效地将无载体制剂气溶胶化。为了评估吸入器的性能,选择了高流量鼻插管 (HFNC) 治疗期间气溶胶肺部输送的挑战性案例研究。主动输送系统包括用于启动装置的通风袋、含有流量控制孔和 3D 棒阵列的 DPI 以及带有单独入口的流线型鼻插管,用于气溶胶和 HFNC 治疗气体。进行了体外实验以评估装置中的沉积、从鼻插管中发射的剂量 (ED) 和粉末解聚。性能最佳的系统实现了 ED 为 70-80%,<5μm 的细颗粒分数为 65-85%,质量中值空气动力学直径为 1.5μm,这是受控凝结生长气溶胶输送的目标条件。将流量控制孔的尺寸从 3.6 减小到 2.3mm,通过手动袋操作使通过系统的流速从平均 35 降低到 15LPM,同时改善了 ED 和雾化性能。新型设备可用于改善机械通气期间的气溶胶输送、鼻到肺的气溶胶给药,以及帮助无法重复使用被动 DPI 的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bf/4051231/f8ba9ce0439d/nihms567154f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bf/4051231/7f394564eac2/nihms567154f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bf/4051231/d0700c0314ec/nihms567154f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bf/4051231/8f744fc36dfc/nihms567154f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bf/4051231/9686ae3a87f9/nihms567154f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bf/4051231/35b4a47d66c9/nihms567154f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bf/4051231/f8ba9ce0439d/nihms567154f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bf/4051231/7f394564eac2/nihms567154f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bf/4051231/d0700c0314ec/nihms567154f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bf/4051231/8f744fc36dfc/nihms567154f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bf/4051231/9686ae3a87f9/nihms567154f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bf/4051231/35b4a47d66c9/nihms567154f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bf/4051231/f8ba9ce0439d/nihms567154f6.jpg

相似文献

1
Development of high efficiency ventilation bag actuated dry powder inhalers.高效通气囊驱动干粉吸入器的研制。
Int J Pharm. 2014 Apr 25;465(1-2):52-62. doi: 10.1016/j.ijpharm.2014.01.043. Epub 2014 Feb 7.
2
Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.使用干粉吸入器实现高效的鼻至肺(N2L)气溶胶递送。
J Aerosol Med Pulm Drug Deliv. 2015 Jun;28(3):189-201. doi: 10.1089/jamp.2014.1158. Epub 2014 Sep 5.
3
Application of an inline dry powder inhaler to deliver high dose pharmaceutical aerosols during low flow nasal cannula therapy.在低流速鼻导管治疗期间,应用直通式干粉吸入器输送高剂量药物气溶胶。
Int J Pharm. 2018 Jul 30;546(1-2):1-9. doi: 10.1016/j.ijpharm.2018.05.011. Epub 2018 May 5.
4
Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.开发一种用于儿童口服或经鼻气溶胶给药的在线干粉吸入器。
J Aerosol Med Pulm Drug Deliv. 2020 Apr;33(2):83-98. doi: 10.1089/jamp.2019.1540. Epub 2019 Aug 29.
5
Initial Development of an Air-Jet Dry Powder Inhaler for Rapid Delivery of Pharmaceutical Aerosols to Infants.用于向婴儿快速递送药物气溶胶的空气喷射干粉吸入器的初步研制。
J Aerosol Med Pulm Drug Deliv. 2021 Feb;34(1):57-70. doi: 10.1089/jamp.2020.1604. Epub 2020 Aug 4.
6
Development of an Inline Dry Powder Inhaler That Requires Low Air Volume.开发一种需要低空气量的在线干粉吸入器。
J Aerosol Med Pulm Drug Deliv. 2018 Aug;31(4):255-265. doi: 10.1089/jamp.2017.1424. Epub 2017 Dec 20.
7
Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.干粉吸入制剂的气溶胶化特性增强生长(EEG)应用:喷雾干燥工艺条件对气溶胶性能的影响。
Int J Pharm. 2013 Feb 25;443(1-2):137-45. doi: 10.1016/j.ijpharm.2013.01.003. Epub 2013 Jan 10.
8
Advancement of a Positive-Pressure Dry Powder Inhaler for Children: Use of a Vertical Aerosolization Chamber and Three-Dimensional Rod Array Interface.正压干粉吸入器在儿童中的应用进展:使用垂直雾化室和三维棒状阵列接口。
Pharm Res. 2020 Aug 30;37(9):177. doi: 10.1007/s11095-020-02889-7.
9
Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations.开发和比较无载体配方的新型高效干粉吸入器。
J Pharm Sci. 2014 Feb;103(2):465-77. doi: 10.1002/jps.23775. Epub 2013 Dec 4.
10
Performance of Low Air Volume Dry Powder Inhalers (LV-DPI) when Aerosolizing Excipient Enhanced Growth (EEG) Surfactant Powder Formulations.低空气量干粉吸入器(LV-DPI)雾化辅料增强生长(EEG)表面活性剂粉末制剂时的性能。
AAPS PharmSciTech. 2021 Apr 15;22(4):135. doi: 10.1208/s12249-021-01998-9.

引用本文的文献

1
Advancement of the Infant Air-Jet Dry Powder Inhaler (DPI): Evaluation of Different Positive-Pressure Air Sources and Flow Rates.婴儿空气射流干粉吸入器(DPI)的改进:不同正压气源和流速的评估。
Pharm Res. 2021 Sep;38(9):1615-1632. doi: 10.1007/s11095-021-03094-w. Epub 2021 Aug 30.
2
Administration of dry powders during respiratory supports.在呼吸支持期间给予干粉剂。
Ann Transl Med. 2021 Apr;9(7):596. doi: 10.21037/atm-20-3946.
3
Advancement of a Positive-Pressure Dry Powder Inhaler for Children: Use of a Vertical Aerosolization Chamber and Three-Dimensional Rod Array Interface.正压干粉吸入器在儿童中的应用进展:使用垂直雾化室和三维棒状阵列接口。
Pharm Res. 2020 Aug 30;37(9):177. doi: 10.1007/s11095-020-02889-7.
4
Development of Dry Powder Inhaler Patient Interfaces for Improved Aerosol Delivery to Children.干粉吸入器患者接口的开发,以改善儿童的气溶胶输送。
AAPS PharmSciTech. 2020 May 25;21(5):157. doi: 10.1208/s12249-020-01667-3.
5
Optimizing Aerosolization Using Computational Fluid Dynamics in a Pediatric Air-Jet Dry Powder Inhaler.使用计算流体动力学优化儿科空气射流干粉吸入器的气溶胶化。
AAPS PharmSciTech. 2019 Nov 1;20(8):329. doi: 10.1208/s12249-019-1535-4.
6
Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.开发一种用于儿童口服或经鼻气溶胶给药的在线干粉吸入器。
J Aerosol Med Pulm Drug Deliv. 2020 Apr;33(2):83-98. doi: 10.1089/jamp.2019.1540. Epub 2019 Aug 29.
7
Use of Computational Fluid Dynamics (CFD) Dispersion Parameters in the Development of a New DPI Actuated with Low Air Volumes.利用计算流体动力学(CFD)弥散参数开发一种新的低空气量驱动的干粉吸入器。
Pharm Res. 2019 May 28;36(8):110. doi: 10.1007/s11095-019-2644-1.
8
Aerosol drug delivery to the lungs during nasal high flow therapy: an in vitro study.鼻高流量治疗期间肺部的药物气溶胶输送:一项体外研究。
BMC Pulm Med. 2019 Feb 15;19(1):42. doi: 10.1186/s12890-019-0807-9.
9
Development of a New Inhaler for High-Efficiency Dispersion of Spray-Dried Powders Using Computational Fluid Dynamics (CFD) Modeling.利用计算流体动力学(CFD)建模开发高效分散喷雾干燥粉末的新型吸入器。
AAPS J. 2019 Feb 7;21(2):25. doi: 10.1208/s12248-018-0281-y.
10
Efficient Nose-to-Lung Aerosol Delivery with an Inline DPI Requiring Low Actuation Air Volume.高效鼻内递药:采用在线 DPI 需低驱动气流。
Pharm Res. 2018 Aug 21;35(10):194. doi: 10.1007/s11095-018-2473-7.

本文引用的文献

1
Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations.开发和比较无载体配方的新型高效干粉吸入器。
J Pharm Sci. 2014 Feb;103(2):465-77. doi: 10.1002/jps.23775. Epub 2013 Dec 4.
2
Development of a high efficiency dry powder inhaler: effects of capsule chamber design and inhaler surface modifications.高效干粉吸入器的研发:胶囊腔室设计及吸入器表面改性的影响
Pharm Res. 2014 Feb;31(2):360-72. doi: 10.1007/s11095-013-1165-6. Epub 2013 Aug 16.
3
The use of condensational growth methods for efficient drug delivery to the lungs during noninvasive ventilation high flow therapy.利用凝聚生长方法在无创通气高流量治疗期间高效递送至肺部的药物。
Pharm Res. 2013 Nov;30(11):2917-30. doi: 10.1007/s11095-013-1123-3. Epub 2013 Jun 26.
4
Influences of cannula size and flow rate on aerosol drug delivery through the Vapotherm humidified high-flow nasal cannula system.管腔大小和流速对经 Vapotherm 湿化高流量鼻导管系统输送雾化药物的影响。
Pediatr Crit Care Med. 2013 Jun;14(5):e250-6. doi: 10.1097/PCC.0b013e31828a7f79.
5
Evaluation and modification of commercial dry powder inhalers for the aerosolization of a submicrometer excipient enhanced growth (EEG) formulation.评估和改进商业干粉吸入器,以实现亚微米尺寸赋形剂增强生长(EEG)制剂的气溶胶化。
Eur J Pharm Sci. 2013 Jun 14;49(3):390-9. doi: 10.1016/j.ejps.2013.04.011. Epub 2013 Apr 19.
6
Aerodynamic factors responsible for the deaggregation of carrier-free drug powders to form micrometer and submicrometer aerosols.载药粉末解聚形成微米和亚微米气溶胶的空气动力学因素。
Pharm Res. 2013 Jun;30(6):1608-27. doi: 10.1007/s11095-013-1001-z. Epub 2013 Mar 8.
7
Improving pharmaceutical aerosol delivery during noninvasive ventilation: effects of streamlined components.改善无创通气时的药物气溶胶输送:流线型部件的影响。
Ann Biomed Eng. 2013 Jun;41(6):1217-32. doi: 10.1007/s10439-013-0759-9. Epub 2013 Feb 20.
8
A novel continuous powder aerosolizer (CPA) for inhalative administration of highly concentrated recombinant surfactant protein-C (rSP-C) surfactant to preterm neonates.一种新型连续粉末雾化器(CPA),用于对早产儿吸入给予高浓度重组表面活性蛋白-C(rSP-C)表面活性剂。
J Aerosol Med Pulm Drug Deliv. 2013 Dec;26(6):370-9. doi: 10.1089/jamp.2012.0996. Epub 2013 Feb 19.
9
Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.干粉吸入制剂的气溶胶化特性增强生长(EEG)应用:喷雾干燥工艺条件对气溶胶性能的影响。
Int J Pharm. 2013 Feb 25;443(1-2):137-45. doi: 10.1016/j.ijpharm.2013.01.003. Epub 2013 Jan 10.
10
Targeting aerosol deposition to and within the lung airways using excipient enhanced growth.利用辅料增强生长作用将气溶胶沉积到肺部气道及其中。
J Aerosol Med Pulm Drug Deliv. 2013 Oct;26(5):248-65. doi: 10.1089/jamp.2012.0997. Epub 2013 Jan 3.